Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,784,246 papers from all fields of science
Search
Sign In
Create Free Account
otelixizumab
Known as:
ChAglyCD3
, Immunoglobulin G1, Anti-(Human CD3 (Antigen)) (Human-Rat Monoclonal Heavy Chain), Disulfide with Human-Rat Monoclonal lambda-Chain, Dimer
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Antibodies, Monoclonal, Humanized
TRX4
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
DIABETIC STUDIES The Review of Chapter IV . 2 CD 3 Monoclonal Antibodies : A First Step Towards Operational Immune Tolerance in the Clinic
L. Chatenoud
,
H. Waldmann
2013
Corpus ID: 20335155
Type 1 diabetes (T1D) is a prototypic organ-specific autoimmune disease resulting from the selective destruction of insulin…
Expand
2012
2012
Ablynx drops lead nanobody
G. Sinha
Nature Biotechnology
2012
Corpus ID: 832692
Prospects for Israeli company Andromeda Biotech were bolstered late last year with the news that its synthetic peptide, DiaPep277…
Expand
2012
2012
India's innovation czar
K. Jayaraman
Nature Biotechnology
2012
Corpus ID: 31119322
Prospects for Israeli company Andromeda Biotech were bolstered late last year with the news that its synthetic peptide, DiaPep277…
Expand
2010
2010
Fasting and stimulated C-peptide at aseline in DEFEND-1, a phase 3 study of otelixizumab in new onset type 1 diabetes
P. Pozzilli
,
G. Ghirlanda
,
A. Brennan
,
B. Bélanger
,
C. Mckee
2010
Corpus ID: 90774307